Skip to main content

Table 5 Medical history of the studied populations and comparison variables between subgroups

From: Cardiovascular risk and the COVID-19 pandemic: a population-based and case‒control studies

Medical history

Group I

N = 691

Group II

N = 816

P

Group III

N = 126

Control group IV

N = 126

P

Ever smoked cigarettes

395 (57.6)

468 (57.6)

0.995

66 (52.4)

82 (65.1)

0.041

Currently smoking

132 (19.3)

154 (19.1)

0.905

8 (6.3)

17 (13.5)

0.058

History of ischemic heart disease

21 (3.0)

35 (4.3)

0.199

7 (5.6)

7 (5.6)

1.000

History of heart failure

9 (1.3)

14 (1.7)

0.513

2 (1.6)

2 (1.6)

1.000

History of stroke

7 (1.0)

9 (1.1)

0.863

3 (2.4)

3 (2.4)

1.000

History of peripheral artery disease

6 (0.9)

11 (1.3)

0.378

3 (2.4)

3 (2.4)

1.000

History of atrial fibrillation

18 (2.6)

40 (4.9)

0.021

7 (5.6)

5 (4.0)

0.554

History of hypertension

196 (28.4)

237 (29.1)

0.760

62 (49.2)

62 (49.2)

1.000

Well-controlled BP in patients diagnosed with hypertension*

50 (25.5)

80 (33.8)

0.077

20 (32.3)

20 (32.3)

1.000

Undiagnosed hypertension

96 (13.9)

94 (11.5)

0.172

12 (9.5)

19 (15.1)

0.179

History of hypercholesterolemia

194 (28.1)

308 (37.8)

< 0.001

64 (50.8)

53 (42.1)

0.165

Well-controlled lipid profile in patients with diagnosed hypercholesterolemia

16 (8.2)

45 (14.6)

0.002

11 (17.1)

3 (5.7)

0.027

Undiagnosed hypercholesterolemia

382 (55.3)

362 (44.4)

< 0.001

54 (42.9)

64 (50.8)

0.207

History of triglyceridemia

104 (15.1)

156 (19.1)

0.036

38 (30.2)

32 (25.4)

0.399

Well-controlled triglyceridemia in patients with diagnosed triglyceridemia§

62 (59.6)

97 (62.2)

0.065

23 (18.4)

18 (14.3)

0.378

Undiagnosed triglyceridemiae

86 (12.4)

108 (13.3)

0.642

19 (15.1)

21 (16.7)

0.730

History of diabetes

43 (6.2)

54 (6.6)

0.756

8 (6.5)

18 (14.3)

0.617

Well controlled glucose in patients diagnosed

with diabetes ||

29 (67.4)

34 (63.0)

0.977

3 (57.5)

14 (77.8)

0.006

Undiagnosed diabetes **

45 (6.5)

48 (5.9)

0.617

12 (9.6)

25 (19.8)

0.022

Antihypertensive drugs

206 (29.8)

239 (29.3)

0.825

56 (44.4)

66 (52.4)

0.207

Anticholesterol drugs

95 (13.7)

122 (15.0)

0.508

30 (23.8)

34 (27.0)

0.563

Antidiabetic drugs

44 (6.4)

62 (7.6)

0.352

9 (7.1)

17 (13.5)

0.098

  1. The data are shown as n (%). BP, blood pressure; BPs, systolic blood pressure; BPd, diastolic blood pressure; CV, cardiovascular; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; OGTT, oral glucose tolerance test; TC, total cholesterol; TG, triglycerides; *BPs < 130 and BPd < 80 mmHg below 65 years old, BPs < 140 and BPd < 80 mmHg 65–80 years old, BPs < 150 and BPd < 80 mmHg over 80 years old; LDL-c < 116 mg% in low CV class, < 100 mg% in moderate CV class, < 70 mg% in high CV class, < 55 mg% in very-high CV class; TC > 190 mg% or LDL-c > 116 mg% in low CV class, > 100 mg% in moderate CV class, > 70 mg% in high CV class, > 55 mg% in very-high CV class; §TG < 150 mg%; eTG>150 mg%; ||HbA1c < 7.0% ** Fasting glucose ≥ 126 mg/dl or OGGT 120 min. glucose ≥ 200 mg/dl or HbA1c ≥ 6,5%